Jorge Reina

Dynamic leader with extensive experience at MYRAK RESEARCH CENTER, adept at business development and implementing innovative training strategies. Proven track record in resolving complex issues and enhancing clinical trial efficiency. Strong analytical skills complemented by exceptional communication abilities, driving successful outcomes in high-pressure environments. Committed to advancing healthcare through strategic collaboration and effective project management.

• MOCA Cognitive Assessment, 03/2023
• EKG, 04/2022
• PHLEBOTOMY, 04/2023
• MEDICAL ASSISTANTS, 05/2022
• GCP with Investigational Drugs and Medical Device, 05/2022
• Clinical Research: An Introduction, 05/2021
• Additional Courses for Protection Of Human Subjects, 05/2022
• Study Coordinator/Key Research Staff (Biomedical), 06/2022
• Shipping and Transport of Regulated Biological Materials, 06/2022
• OSHA, 06/2023
• Emergency and Incident Response to Biohazard Spill and Releases, 06/2022
• HIPS, 05/2022
• GCP, 05/2022

· Randomized Controlled Phase IIa, Two-arm Study to Assess the Safety and Efficacy of Human Umbilical Cord Blood (RegeneCyte) Infusion in Patients with Post-COVID Syndrome

· Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of EDP-938 in Non-hospitalized Adults with Acute Respiratory Syncytial Virus Infection who are at High Risk for Complications

· PCR Home test platform: A molecular test for the detection of SARS-CoV-2 for non-laboratory use

· Clinical Validation of the OSANG GeneFinder™ COVID-19 Ag Home Test in anterior nasal samples For Over-The-Counter (OTC) Use

· Clinical Validation of Princeton BioMeditech Corp. Over-the-Counter (OTC) Status™ COVID-19 Antigen Test in Anterior Nasal Samples from Symptomatic Subjects

· Clinical Validation of the Roche Diagnostics COVID-19 At-Home Test in Nasal Swab Samples For Over-The-Counter (OTC) Use

· Clinical Validation of Xtrava Over-the-Counter (OTC) SPERA™ COVID-19 Antigen Home Test in Anterior Nasal Samples.

· Human Factors and Clinical Validation of ANP Over-the-Counter (OTC) NIDS COVID-19 Antigen Home Test in Anterior Nasal Samples from Symptomatic Subjects

· Clinical Evaluation of MaximBio’s Prescription Home Use SARS-CoV-2 Rapid Antigen Test in Anterior Nares Samples

· A Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of Liquid Alpha1-Proteinase Inhibitor (Human) plus Standard Medical Treatment (SMT) versus Placebo plus SMT in Hospitalized Subjects with COVID-19

·  Phase 3, Randomized, Double-Blind, Placebo Controlled Study Assessing the Efficacy and Safety of Anti-Spike SARS Cov-2 Monoclonal Antibodies for Prevention of SARs Cov-2 Infection and Covid-19 in at Risk Subjects)

· Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Assessing the Efficacy and Safety of Anti-Spike SARS COV-2 Monoclonal Antibodies for Prevention of SARS COV-2 Infection and COVID-19 in At-Risk Subjects 

· Clinical Validation of the Arion Bio GlowTest COVID-19 Antigen Home Test in anterior nasal samples for Over-the-Counter (OTC) Use

· Clinical Validation of the Mologic Prescription Home Use and Over-the-Counter (OTC) SARS-CoV-2 Ag Home Test in Anterior Nasal Samples from Symptomatic and Asymptomatic Subjects

· COVID-19 Outpatient Thrombosis Prevention Trial within ACTIV-4: A multicenter adaptive randomized placebo-controlled platform trial evaluating the efficacy and safety of antithrombotic strategies in COVID-19 adults not requiring hospitalization at time of diagnosis.

·Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Assessing the Efficacy and Safety of Anti-Spike SARS-CoV-2 Monoclonal Antibodies in Preventing SARS-Cov-2 Infection in Household Contacts of Individuals Infected with SARS-CoV-2

· Pre-Clinical Evaluation of the BinaxN0W™ C0VID-19 /Flu A&B Combo Self Test

· Phase 2B, Three-arm, Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial to Assess the Efficacy, Safety, and Tolerability of a Repeat Dose of Fasedienol (PH94B) Nasal Spray for the Acute Treatment of Anxiety Induced by a Public Speaking Challenge in Adult Subjects with Social Anxiety Disorder, with an Open-Label Extension.